Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835].

Source:http://linkedlifedata.com/resource/pubmed/id/16776849

Download in:

View as

General Info

PMID
16776849